CEO Sells $3.9 Million in Company Stock
UTI has more than doubled off its 52-week low of $21.29.
Summary
CEO and Director Jerome Alan Grant sold $3.9 million worth of company stock, citing personal tax planning, adding to a recent trend of significant insider selling.
Key Events · Ownership and Investor Activity · UTI
-
CEO Sells Shares
Jerome Alan Grant, CEO and Director, sold 94,500 shares of company stock for a total value of $3,912,306 on June 29, 2026, at prices ranging from $41.15 to $41.63 per share.
-
Tax Planning Cited
The filing indicates these shares were sold by the reporting person for personal tax planning purposes.
-
Adds to Recent Insider Selling Trend
This transaction follows a Form 144 filed by Mr. Grant on June 29, 2026, for the same amount, and occurs amidst a broader trend of significant insider selling totaling over $125 million by 8 active insiders in the last 90 days.
Analysis · UTI · Trade & Services
This Form 4 reports a significant sale of company stock by CEO and Director Jerome Alan Grant, totaling nearly $4 million. While the filing notes the sale was for personal tax planning, a disposition of this magnitude by a key executive can be interpreted negatively by the market, especially as it adds to a pattern of substantial insider selling observed over the past three months, which totals over $125 million. This transaction confirms the intent to sell previously disclosed in a Form 144 filed on the same day.
At the time of this filing, UTI was trading at $42.77 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $21.29 to $45.74. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.